High mRNA expression of TIGIT was significantly connected to favorable OS (HR: 0.67 (0.49–0.92); P=0.012) (Figure 2E) and RFS (HR: 0.77 (0.66–0.9); P=0.0011) (Figure 2F) in breast cancer patients. Here, TIGIT is linked to breast cancer.